Iradimed Co revenue growth has been varied year-over-year.

What is IRMD's revenue growth rate?

Historical revenue data is available for Iradimed Co to analyze growth trends.

How fast is IRMD earnings growing?

Earnings growth data is available for Iradimed Co analysis.

What is IRMD's profit margin?

Profit margin data is available for Iradimed Co.

IRMD Revenue & Earnings Growth Analysis 2026 - Is Iradimed Co Growing?

Growth Summary

Iradimed Co (IRMD) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.

Over the past 4 years, Iradimed Co has achieved a revenue compound annual growth rate (CAGR) of 23.3%, while earnings have grown at 93.6% CAGR.

Latest Revenue

$73.24M

Net Income

$19.23M

5-Year Revenue CAGR

23.3%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Iradimed Co

The chart above illustrates Iradimed Co's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Iradimed Co's business.

Profit Margin Trends

How efficiently Iradimed Co converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Iradimed Co retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$2.08

Current: $1.52

EPS Estimate 2027

$2.32

11.5% expected growth

Price Target

$118.67

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Iradimed Co to continue growing earnings in the coming year. The consensus analyst rating is 4.5 based on 2 analysts.

Growth Analysis Conclusion

Based on our comprehensive analysis, Iradimed Co (IRMD) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, 23.3% CAGR over 4 years
Profitability: demonstrates the company is profitable
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Iradimed Co's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.